Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor. 1990

J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
Laboratoire de Chimie Bio-Organique associé au CNRS (URA 1386), Université Louis Pasteur, Strasbourg, France.

The synthesis of aryldiazonium and arylazido derivatives of carfentanil, etonitazene, and naltrexone and of a triazaspirodecane derivative is described. The chemical stability and the spectral characteristics of these compounds were verified, and their binding affinity constants for the different opioid receptor classes were determined, in the absence of light, from competition experiments. With the exception of the naltrexyl derivatives, which remained nonselective, all compounds tested displayed a pronounced mu-binding selectivity with mu/delta and mu/kappa ratios ranging from 12 to 1000. After irradiation, only the arylazido probes led to an irreversible mu-binding-site inactivation. This inactivation fulfilled the criteria for photoaffinity labeling such as protection against inactivation by other opiate ligands and absence of an effect of scavengers on the extent of the inactivation. Most of the photoactivatable probes formed long-lasting reversible complexes with the opioid binding sites: an efficient dissociation procedure was thus required to discriminate between pseudoirreversible and covalent complexes. The marked differences in labeling efficacy between aryldiazonium salts and their corresponding arylazido derivatives are discussed.

UI MeSH Term Description Entries
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000345 Affinity Labels Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. Affinity Labeling Reagents,Labeling Reagents, Affinity,Labels, Affinity,Reagents, Affinity Labeling
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001386 Azides Organic or inorganic compounds that contain the -N3 group. Azide
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
October 2005, The AAPS journal,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
January 1990, Progress in clinical and biological research,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
January 1986, Neuropeptides,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
December 1984, Journal of medicinal chemistry,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
June 2004, Medical science monitor : international medical journal of experimental and clinical research,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
September 2009, Zebrafish,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
November 1985, FEBS letters,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
November 1994, The Journal of pharmacology and experimental therapeutics,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
January 1989, NIDA research monograph,
J L Galzi, and A Mejean, and B Ilien, and C Mollereau, and J C Meunier, and M Goeldner, and C Hirth
July 1995, The Journal of biological chemistry,
Copied contents to your clipboard!